1-4 of 4
Mollie E. Moran, CRNP
Close
Sort by
Journal Articles

Phase I Dose Escalation Study of Flavopiridol in Combination with Fludarabine and Rituximab: Activity in Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma.

Thomas S. Lin, MD, PhD, Beth Fischer, MSN, Mollie E. Moran, CRNP, David M. Lucas, PhD, Roshini S. Shank, BA, Eric H. Kraut, MD, Sheriff S. Farag, MD, PhD, Margaret S. Lucas, PA-C, Alexander D. Colevas, MD, Michael R. Grever, MD, John C. Byrd, MD
Journal: Blood
Blood (2004) 104 (11): 2492.
https://doi.org/10.1182/blood.V104.11.2492.2492
Published: 2004
Journal Articles

Effects of the Redox Mediator Motexafin Gadolinium in a Pilot Phase I Trial in Refractory Chronic Lymphocytic Leukemia (CLL).

Thomas S. Lin, MD, PhD, Sabyasachi Biswas, PhD, Louie Naumovski, MD, PhD, Phillip Lecane, PhD, Margaret S. Lucas, PA-C, Mollie E. Moran, CRNP, Andrew P. Mone, MD, PhD, David M. Lucas, PhD, See-Chun Phan, MD, Richard A. Miller, MD, John C. Byrd, MD
Journal: Blood
Blood (2004) 104 (11): 3486.
https://doi.org/10.1182/blood.V104.11.3486.3486
Published: 2004
Journal Articles

Flavopiridol Administered as a Pharmacologically-Derived Schedule Demonstrates Marked Clinical Activity in Refractory, Genetically High Risk, Chronic Lymphocytic Leukemia (CLL).

John C. Byrd, MD, Thomas S. Lin, MD, Phd, James T. Dalton, PhD, Di Wu, PhD, Beth Fischer, MSN, Mollie E. Moran, CRNP, Kristie A. Blum, MD, Roshini S. Shank, BA, David M. Lucas, PhD, Margaret S. Lucas, PA-C, Jose-Ramon Suarez, MD, Michael R. Grever, MD
Journal: Blood
Blood (2004) 104 (11): 341.
https://doi.org/10.1182/blood.V104.11.341.341
Published: 2004
Journal Articles

A Phase II Study of the TNF-α Inhibitor Etanercept and Thrice Weekly Rituximab: Evidence of Clinical Activity in the Absence of del(17p13.1) Genomic Abnormalities.

Thomas S. Lin, MD, PhD, Nyla A. Heerema, PhD, Jennifer Swenor, Margaret S. Lucas, PA-C, Mollie E. Moran, CRNP, Carolyn M. Cheney, MS, David M. Lucas, PhD, Donn Young, PhD, Michael A. Caligiuri, MD, Michael R. Grever, MD, John C. Byrd, MD
Journal: Blood
Blood (2004) 104 (11): 3469.
https://doi.org/10.1182/blood.V104.11.3469.3469
Published: 2004